Coronavirus immunogenic compositions and uses thereof
AssigneeAltimmune Inc.
InventorsBertrand Victor Gilbert Georges, M. Scot Roberts
Life of this patent
Estimating the term…
Abstract
CORONAVIRUS IMMUNOGENIC COMPOSITIONS AND USES THEREOF Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
Claims33
1-62. (canceled)
An immunogenic composition comprising a replication defective adenoviral (rdAd) vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 446 or a variant comprising at least 95% identity to SEQ ID NO:
- 446.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
An immunogenic composition comprising a replication defective adenoviral (rdAd) vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 15 or a variant comprising at least 95% identity to SEQ ID NO:
- 15.
An immunogenic composition comprising an Ad5 human adenovirus replication defective adenoviral (rdAd) vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 15 or a variant comprising at least 95% identity to SEQ ID NO:
- 15.
Dependencies are inferred from the claim text.